Chemistry of Biomacromolecules: Current Research Articles
Current Articles about the Chemistry of Biomacromolecules published in scientific online journals.
The author- or copyrights of the listed
research articles below
are held by the respective authors or site operators, who are also responsible
for the content of the presentations.
To search
this web page for specific words type "Ctrl" + "F" on your keyboard
(Command + "F" on a Mac). Then: type the word you are searching for in
the window that pops up!
To list your
article here plaease contact us by eMail.
On this page considered biochemistry journals:
BMC Structural Biology - published by
BioMed Central -
... is an open access journal publishing original peer-reviewed research articles in investigations into the structure and function of biological macromolecules.
Biomacromolecules - published by
The American Chemical Society -
... explores the interactions of macromolecules with biological systems and their environments as well as biological approaches to the design of polymeric materials. Cutting-edge research at the interface of polymer science and biological sciences.
Current research articles of the mentioned
journals:
Background:
GPR17 is a hybrid G-protein-coupled receptor (GPCR) activated by two unrelated ligand families, extracellular nucleotides and cysteinyl-leukotrienes (cysteinyl-LTs), and involved in brain damage and repair. Its exploitment as a target for novel neuro-reparative strategies depends on the elucidation of the molecular determinants driving binding of purinergic and leukotrienic ligands. Here, we applied docking and molecular dynamics simulations (MD) to analyse the binding and the forced unbinding of two GPR17 ligands (the endogenous purinergic agonist UDP and the leukotriene receptor antagonist pranlukast from both the wild-type (WT) receptor and a mutant model, where a basic residue hypothesized to be crucial for nucleotide binding had been mutated (R255I) to Ile.
Results:
MD suggested that GPR17 nucleotide binding pocket is enclosed between the helical bundle and extracellular loop (EL) 2. The driving interaction involves R255 and the UDP phosphate moiety. To support this hypothesis, steered MD experiments showed that the energy required to unbind UDP is higher for the WT receptor than for R255I. Three potential binding sites for pranlukast where instead found and analysed. In one of its preferential docking conformations, pranlukast tetrazole group is close to R255 and phenyl rings are placed into a subpocket highly conserved among GPCRs. Pulling forces developed to break polar and aromatic interactions of pranlukast were comparable. No differences between the WT receptor and the R255I receptor were found for the unbinding of pranlukast.
Conclusions:
These data thus suggest that, in contrast to which has been hypothesized for nucleotides, the lack of the R255 residue doesn't affect the binding of pranlukast a crucial role for R255 in binding of nucleotides to GPR17. Aromatic interactions are instead likely to play a predominant role in the recognition of pranlukast, suggesting that two different binding subsites are present on GPR17.
Background:
Human blood coagulation factor VIII (fVIII) is a large plasma glycoprotein with sequential domain arrangement in the order A1-a1-A2-a2-B-a3-A3-C1-C2. The A1, A2 and A3 domains are interconnected by long linker peptides (a1, a2 and a3) that possess the activation sites. Proteolysis of fVIII zymogen by thrombin or factor Xa results in the generation of the activated form (fVIIIa) which serves as a critical co-factor for factor IXa (fIXa) enzyme in the intrinsic coagulation pathway.
Results:
In our efforts to elucidate the structural differences between fVIII and fVIIIa, we developed the solution structural models of both forms, starting from an incomplete 3.7 Å X-ray crystal structure of fVIII zymogen, using explicit solvent MD simulations. The full assembly of B-domainless single-chain fVIII was built between the A1-A2 (Ala1-Arg740) and A3-C1-C2 (Ser1669-Tyr2332) domains. The structural dynamics of fVIII and fVIIIa, simulated for over 70 ns of time scale, enabled us to evaluate the integral motions of the multi-domain assembly of the co-factor and the possible coordination pattern of the functionally important calcium and copper ion binding in the protein.
Conclusions:
MD simulations predicted that the acidic linker peptide (a1) between the A1 and A2 domains is largely flexible and appears to mask the exposure of putative fIXa enzyme binding loop (Tyr555-Asp569) region in the A2 domain. The simulation of fVIIIa, generated from the zymogen structure, predicted that the linker peptide (a1) undergoes significant conformational reorganization upon activation by relocating completely to the A1-domain. The conformational transition led to the exposure of the Tyr555-Asp569 loop and the surrounding region in the A2 domain. While the proposed linker peptide conformation is predictive in nature and warrants further experimental validation, the observed conformational differences between the zymogen and activated forms may explain and support the large body of experimental data that implicated the critical importance of the cleavage of the peptide bond between the Arg372 and Ser373 residues for the full co-factor activity of fVIII.
Background:
Catalytic activity of influenza neuraminidase (NA) facilitates elution of progeny virions from infected cells and prevents their self-aggregation mediated by the catalytic site located in the body region. Research on the active site of the molecule has led to development of effective inhibitors like oseltamivir, zanamivir etc, but the high rate of mutation and interspecies reassortment in viral sequences and the recent reports of oseltamivir resistant strains underlines the importance of determining additional target sites for developing future antiviral compounds. In a recent computational study of 173 H5N1 NA gene sequences we had identified a 50-base highly conserved region in 3'-terminal end of the NA gene.
Results:
We extend the graphical and numerical analyses to a larger number of H5N1 NA sequences (514) and H1N1 swine flu sequences (425) accessed from GenBank. We use a 2D graphical representation model for the gene sequences and a Graphical Sliding Window Method (GSWM) for protein sequences scanning the sequences as a block of 16 amino acids at a time. Using a protein sequence descriptor defined in our model, the protein sliding scan method allowed us to compare the different strains for block level variability, which showed significant statistical correlation to average solvent accessibility of the residue blocks; single amino acid position variability results in no correlation, indicating the impact of stretch variability in chemical environment. Close to the C-terminal end the GSWM showed less descriptor-variability with increased average solvent accessibility (ASA) that is also supported by conserved predicted secondary structure of 3' terminal RNA and visual evidence from 3D crystallographic structure.
Conclusion:
The identified terminal segment, strongly conserved in both RNA and protein sequences, is especially significant as it is surface exposed and structural chemistry reveals the probable role of this stretch in tetrameric stabilization. It could also participate in other biological processes associated with conserved surface residues. A RNA double hairpin secondary structure found in this segment in a majority of the H5N1 strains also supports this observation. In this paper we propose this conserved region as a probable site for designing inhibitors for broad-spectrum pandemic control of flu viruses with similar NA structure.
Background:
Template-target sequence alignment and loop modeling are key components of protein comparative modeling. Short loops can be predicted with high accuracy using structural fragments from other, not necessairly homologous proteins, or by various minimization methods. For longer loops multiscale approaches employing coarse-grained de novo modeling techniques should be more effective.
Results:
For a representative set of protein structures of various structural classes test predictions of loop regions have been performed using MODELLER, ROSETTA, and a CABS coarse-grained de novo modeling tool. Loops of various length, from 4 to 25 residues, were modeled assuming an ideal target-template alignment of the remaining portions of the protein. It has been shown that classical modeling with MODELLER is usually better for short loops, while coarse-grained de novo modeling is more effective for longer loops. Even very long missing fragments in protein structures could be effectively modeled. Resolution of such models is usually on the level 2-6 Å, which could be sufficient for guiding protein engineering. Further improvement of modeling accuracy could be achieved by the combination of different methods. In particular, we used 10 top ranked models from sets of 500 models generated by MODELLER as multiple templates for CABS modeling. On average, the resulting molecular models were better than the models from individual methods.
Conclusions:
Accuracy of protein modeling, as demonstrated for the problem of loop modeling, could be improved by the combinations of different modeling techniques.
Background:
The emergence of structural genomics presents significant challenges in the annotation of biologically uncharacterized proteins. Unfortunately, our ability to analyze these proteins is restricted by the limited catalog of known molecular functions and their associated 3D motifs.
Results:
In order to identify novel 3D motifs that may be associated with molecular functions, we employ an unsupervised, two-phase clustering approach that combines k-means and hierarchical clustering with knowledge-informed cluster selection and annotation methods. We applied the approach to approximately 20,000 cysteine-based protein microenvironments (3D regions 7.5 Å in radius) and identified 70 interesting clusters, some of which represent known motifs (e.g. metal binding and phosphatase activity), and some of which are novel, including several zinc binding sites. Detailed annotation results are available online for all 70 clusters at http://feature.stanford.edu/clustering/cys.
Conclusions:
The use of microenvironments instead of backbone geometric criteria enables flexible exploration of protein function space, and detection of recurring motifs that are discontinuous in sequence and diverse in structure. Clustering microenvironments may thus help to functionally characterize novel proteins and better understand the protein structure-function relationship.
Background:
Sliding clamps, such as Proliferating Cell Nuclear Antigen (PCNA) in eukaryotes, are ring-shaped protein complexes that encircle DNA and enable highly processive DNA replication by serving as docking sites for DNA polymerases. In an ATP-dependent reaction, clamp loader complexes, such as the Replication Factor-C (RFC) complex in eukaryotes, open the clamp and load it around primer-template DNA.
Results:
We built a model of RFC bound to PCNA and DNA based on existing crystal structures of clamp loaders. This model suggests that DNA would enter the clamp at an angle during clamp loading, thereby interacting with positively charged residues in the center of PCNA. We show that simultaneous mutation of Lys 20, Lys 77, Arg 80, and Arg 149, which interact with DNA in the RFC-PCNA-DNA model, compromises the ability of yeast PCNA to stimulate the DNA-dependent ATPase activity of RFC when the DNA is long enough to extend through the clamp. Fluorescence anisotropy binding experiments show that the inability of the mutant clamp proteins to stimulate RFC ATPase activity is likely caused by reduction in the affinity of the RFC-PCNA complex for DNA. We obtained several crystal forms of yeast PCNA-DNA complexes, measuring X-ray diffraction data to 3.0 Å resolution for one such complex. The resulting electron density maps show that DNA is bound in a tilted orientation relative to PCNA, but makes different contacts than those implicated in clamp loading. Because of apparent partial disorder in the DNA, we restricted refinement of the DNA to a rigid body model. This result contrasts with previous analysis of a bacterial clamp bound to DNA, where the DNA was well resolved.
Conclusion:
Mutational analysis of PCNA suggests that positively charged residues in the center of the clamp create a binding surface that makes contact with DNA. Disruption of this positive surface, which had not previously been implicated in clamp loading function, reduces RFC ATPase activity in the presence of DNA, most likely by reducing the affinity of RFC and PCNA for DNA. The interaction of DNA is not, however, restricted to one orientation, as indicated by analysis of the PCNA-DNA co-crystals.
Background:
The soluble guanylyl cyclase (sGC) is a heterodimeric enzyme that, upon activation by nitric oxide, stimulates the production of the second messenger cGMP. Each sGC subunit harbor four domains three of which are used for heterodimerization: H-NOXA/H-NOBA domain, coiled-coil domain (CC), and catalytic guanylyl cyclase domain. The CC domain has previously been postulated to be part of a larger CC family termed the signaling helix (S-helix) family. Homodimers of sGC have also been observed but are not functionally active yet are likely transient awaiting their intended heterodimeric partner.
Results:
To investigate the structure of the CC S-helix region, we crystallized and determined the structure of the CC domain of the sGCβ1 subunit comprising residues 348-409. The crystal structure was refined to 2.15 Å resolution.
Conclusions:
The CC structure of sGCβ1 revealed a tetrameric arrangement comprised of a dimer of CC dimers. Each monomer is comprised of a long a-helix, a turn near residue P399, and a short second a-helix. The CC structure also offers insights as to how sGC homodimers are not as stable as (functionally) active heterodimers via a possible role for inter-helix salt-bridge formation. The structure also yielded insights into the residues involved in dimerization. In addition, the CC region is also known to harbor a number of congenital and man-made mutations in both membrane and soluble guanylyl cyclases and those function-affecting mutations have been mapped onto the CC structure. This mutant analysis indicated an importance for not only certain dimerization residue positions, but also an important role for other faces of the CC dimer which might perhaps interact with adjacent domains. Our results also extend beyond guanylyl cyclases as the CC structure is, to our knowledge, the first S-helix structure and serves as a model for all S-helix containing family members.
Background:
Nonribosomal peptide synthetases (NRPSs) are multienzymatic, multidomain megasynthases involved in the biosynthesis of pharmaceutically important nonribosomal peptides. The peptaibol synthetase from Trichoderma virens (TPS) is an important member of the NRPS family that exhibits antifungal properties. The majority of the NRPSs terminate peptide synthesis with the thioesterase (TE) domain, which either hydrolyzes the thioester linkage, releasing the free peptic acid, or catalyzes the intramolecular macrocyclization to produce a macrolactone product. TPS is an important NRPS that does not encompass a TE domain, but rather a reductase domain (R domain) to release the mature peptide product reductively with the aid of a NADPH cofactor. However, the catalytic mechanism of the reductase domain has not yet been elucidated.
Results:
We present here a three-dimensional (3D) model of the reductase domain based on the crystal structure of vestitone reductase (VR). VR belongs to the short-chain dehydrogenase/reductase (SDR) superfamily and is responsible for the nicotinamide dinucleotide phosphate (NADPH)-dependent reduction of the substrate into its corresponding secondary alcohol product. The binding sites of the probable linear substrates, alamethicin, trichotoxin, antiamoebin I, chrysopermin C and gramicidin, were identified within the modeled R domain using multiple docking approaches. The docking results of the ligand in the active site of the R domain showed that reductase side chains have a high affinity towards ligand binding, while the thioester oxygen of each substrate forms a hydrogen bond with the OH group of Tyr176 and the thiol group of the substrate is closer to the Glu220. The modeling and docking studies revealed the reaction mechanism of reduction of thioester into a primary alcohol.
Conclusion:
Peptaibol biosynthesis incorporates a single R domain, which appears to catalyze the four-electron reduction reaction of a peptidyl carrier protein (PCP)-bound peptide to its corresponding primary alcohol. Analysis of R domains present in the non-redundant (nr) database of the NCBI showed that the R domain always resides in the last NRPS module and is involved in either a two or four-electron reduction reaction.
Background:
Setting the rules for the identification of a stable conformation of a protein is of utmost importance for the efficient generation of structures in computer simulation. For structure prediction, a considerable number of possible models are generated from which the best model has to be selected.
Results:
Two scoring functions, Rs and Rp, based on the consideration of packing of residues, which indicate if the conformation of an amino acid sequence is native-like, are presented. These are defined using the solvent accessible surface area (ASA) and the partner number (PN) (other residues that are within 4.5 Å) of a particular residue. The two functions evaluate the deviation from the average packing properties (ASA or PN) of all residues in a polypeptide chain corresponding to a model of its three-dimensional structure. While simple in concept and computationally less intensive, both the functions are at least as efficient as any other energy functions in discriminating the native structure from decoys in a large number of standard decoy sets, as well as on models submitted for the targets of CASP7. Rs appears to be slightly more effective than Rp, as determined by the number of times the native structure possesses the minimum value for the function and its separation from the average value for the decoys.
Conclusion:
Two parameters, Rs and Rp, are discussed that can very efficiently recognize the native fold for a sequence from an ensemble of decoy structures. Unlike many other algorithms that rely on the use of composite scoring function, these are based on a single parameter, viz., the accessible surface area (or the number of residues in contact), but still able to capture the essential attribute of the native fold.
Background:
Many Gram-positive lactic acid bacteria (LAB) produce anti-bacterial peptides and small proteins called bacteriocins, which enable them to compete against other bacteria in the environment. These peptides fall structurally into three different classes, I, II, III, with class IIa being pediocin-like single entities and class IIb being two-peptide bacteriocins. Self-protective cognate immunity proteins are usually co-transcribed with these toxins. Several examples of cognates for IIa have already been solved structurally. Streptococcus pyogenes, closely related to LAB, is one of the most common human pathogens, so knowledge of how it competes against other LAB species is likely to prove invaluable.
Results:
We have solved the crystal structure of the gene-product of locus Spy_2152 from S. pyogenes, (PDB:2fu2), and found it to comprise an anti-parallel four-helix bundle that is structurally similar to other bacteriocin immunity proteins. Sequence analyses indicate this protein to be a possible immunity protein protective against class IIa or IIb bacteriocins. However, given that S. pyogenes appears to lack any IIa pediocin-like proteins but does possess class IIb bacteriocins, we suggest this protein confers immunity to IIb-like peptides.
Conclusions:
Combined structural, genomic and proteomic analyses have allowed the identification and in silico characterization of a new putative immunity protein from S. pyogenes, possibly the first structure of an immunity protein protective against potential class IIb two-peptide bacteriocins. We have named the two pairs of putative bacteriocins found in S. pyogenes pyogenecin 1, 2, 3 and 4.
The author- or copyrights of the listed Internet pages
are held by the respective authors or site operators, who are also responsible
for the content of the presentations.
To add your company or product site to this index please use the
registration form or send us a eMail.
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 11, Issue 3, Page 754-761, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 610-616, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 555-560, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 583-592, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 787-796, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 713-720, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 682-689, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 690-697, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 806-814, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 575-582, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 666-673, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 533-541, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 762-768, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 706-712, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 593-599, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 561-567, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 600-609, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 820-826, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 748-753, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 827-831, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 769-775, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 643-647, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 815-819, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 797-805, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 674-681, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 568-574, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 657-665, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 698-705, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 542-548, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 721-730, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 626-634, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 617-625, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 731-739, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 740-747, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 635-642, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 549-554, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 648-656, March 8, 2010.
Biomacromolecules, Volume 11, Issue 3, Page 776-786, March 8, 2010.
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).
Biomacromolecules, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable).